Will patients with meniscal tear who continue to experience pain following a course of Physical Therapy (PT) enroll in a trial comparing further nonoperative therapy with surgery? a qualitative study

接受物理治疗(PT)后疼痛持续存在的半月板撕裂患者是否愿意参与一项比较进一步非手术治疗与手术治疗的临床试验?一项定性研究

阅读:3

Abstract

BACKGROUND: We aimed to conduct a qualitative prospective preference assessment (PPA) to assess participants’ willingness to enroll in a planned randomized controlled trial (RCT). The planned RCT would enroll participants with meniscal tear with persistent knee pain following a course of physical therapy (PT) and would compare outcomes of arthroscopic partial meniscectomy (APM) vs. enhanced conservative care. METHODS: We identified participants 45–85 years old with suspected meniscal tear who were referred to PT. After 10 weeks of PT, participants were sent a questionnaire that assessed knee pain. We asked participants reporting persistent knee pain to participate in a follow-up interview. We conducted semi-structured interviews and coded and analyzed transcripts to identify themes related to enrollment in our planned RCT. RESULTS: We analyzed transcripts from twenty participants (mean age (SD): 61.6 (6.16); 60% male, 100% White). 70% said they would participate in the trial. Willingness to enroll was associated with participants’ preferences for treatment modality and most were willing to continue PT, despite reporting persistent pain. Of those unwilling to enroll, all were averse to surgery or did not believe they needed surgery. Others had concerns about oral medications and injections, but these were not “dealbreakers” for willingness to enroll. Provider trust was a dominant decision-making factor in respondents’ willingness to enroll. CONCLUSION: These findings suggest that investigators should consider additional education for participants regarding the benefits and risks of all treatment options at the time of enrollment invitation. Additionally, the trial should be introduced by a trusted provider. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-026-09521-6.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。